Granulocyte macrophage colony-stimulating factor and interleukin 4 enhance the number and antigen-presenting activity of circulating CD14+ and CD83+ cells in cancer patients.
Cancer Res. 2000 Apr 1;60(7):1934-41.
Cancer Res. 2000.
PMID: 10766183
Clinical Trial.